For patients suffering from chronic, severe back pain that hasn’t responded to traditional treatments, a spinal cord stimulator (SCS) may offer new hope.Dr. Je ...
Abbott’s five-year data highlighted neuromodulation therapies’ role in reducing healthcare and patient burdens associated ...
Credit: Shutterstock. Study participants suffered from chronic back pain for an average of 12.8 years. The Food and Drug Administration (FDA) has expanded the approval of Abbott’s spinal cord ...
The FDA approved Abbott Laboratories ABT spinal cord stimulation (SCS) devices for chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back ...
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...
“The approval of the Proclaim Elite recharge-free SCS system is a needed advancement for both patients and physicians who now have access to a low-maintenance chronic pain treatment that can reduce ...
Chronic pain affects millions of individuals, considerably impacting their quality of life and emotional well-being. You may find that it alters your daily activities, leading to frustration and ...
LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...
Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts ...
Joseph Jeanmarie has had back problems since the 1980s, when he injured his back and had surgery. Although his chronic pain was sometimes debilitating, he continued his work as an insurance ...